Nano-curcumin potentiates antitumor immunity in prostate cancer via co-culture with adipose-derived mesenchymal stem cells
Open Access
- 15 October 2025
- journal article
- research article
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 25 (1) , 1-12
Abstract
Curcumin is a polyphenolic compound from Curcuma longa that exhibits immunoregulatory and anti-cancer properties. It is formulated as nano-curcumin. Mesenchymal stem cells (MSCs) also show anticancer effects and can potentially activate resting immune cells. This study investigates the combined effects of nano-curcumin and adipose-derived mesenchymal stem cells (ASCs) on peripheral blood mononuclear cells (PBMCs) isolated from prostate cancer (PCa) patients. ASCs were isolated and characterized. PBMCs were isolated from patients and co-cultured with and without ASCs in the presence of different concentrations of nano-curcumin to examine cell survival using the MTT assay. Based on the results of the MTT assay, selected concentrations of nano-curcumin were used to investigate apoptosis and cell subpopulations of PBMCs in co-culture with ASCs using apoptosis assay and flow cytometry. Nano-curcumin increased PBMC survival at concentrations of 3, 6, 12, 25, and 50 µM in co-culture with ASCs. In the absence of ASCs, a significant increase in PBMC survival was observed at concentrations of 6, 12, 25, 50, and100 µM. Concentrations of 6 and 12 µM caused a significant reduction in apoptosis. A concentration of 12 µM increased the number of CD3+CD4+ cells, and the number of CD3+CD8+ cells increased at concentrations of 6 and 25 µM. At a concentration of 25 µM, the number of CD45+CD19+ cells was significantly increased. Nano-curcumin in combination with ASCs has the potential to affect immune cells, indicating its potential as a complementary therapy for use in cancer. Further research is required to confirm these findings.Keywords
Funding Information
- Mashhad University of Medical Sciences (4031454)
This publication has 32 references indexed in Scilit:
- The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial.2016
- Curcumin and tumor immune-editing: resurrecting the immune systemCell Division, 2015
- Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitroInternational Immunopharmacology, 2012
- Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunityInternational Immunopharmacology, 2011
- Curcumin, myrecen and cineol modulate the percentage of lymphocyte subsets altered by 2,3,7, 8-Tetracholorodibenzo-p-dioxins (TCDD) in ratsHuman & Experimental Toxicology, 2011
- Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinomaCancer Letters, 2010
- Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hostsCellular & Molecular Immunology, 2010
- Human Bone Marrow-Derived Mesenchymal Stromal Cells Expressing S-TRAIL as a Cellular Delivery Vehicle for Human Glioma TherapyStem Cells, 2009
- Curcumin Prevents Tumor-induced T Cell Apoptosis through Stat-5a-mediated Bcl-2 InductionJournal of Biological Chemistry, 2007
- Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcuminCancer Detection Prevention, 2005